Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Congenital hypertrophy of the lateral nail folds of the hallux: clinical features and follow-up of seven cases
With oral formulations gaining regulatory approvals and commercial traction, advancements in drug delivery represent a critical driver shaping the future growth of this market
This has created a strong push for domestic manufacturing, especially with patent expiries and government Competitive Landscape: Key Players and Pipeline Developments: Market Leaders and Innovators Novo Nordisk dominates the current Indian GLP-1 market, primarily through oral semaglutide (Rybelsus), which holds approximately 69% market share as of recent reports
In agreement with our results, several studies showed that the amount of NO increased in the PFC in psychiatric conditions like depression (30, 31)
Built for Canadian Research
